TrialNeurology(R) neuroimmunology & neuroinflammation2021

B-Cell Activity Predicts Response to Glatiramer Acetate and Interferon in Relapsing-Remitting Multiple Sclerosis.

Sabine Tacke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.